AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Milestone Scientific Inc.
Video analysis: MLSS
All videosNo video analysis for this stock yet. Request one from our team.
News: MLSS
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Reports Financial Results for Second Quarter 2026
Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales ROSELAND, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and six months ended June 30, 2026.
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company's financial results for the second quarter ended June 30, 2026, as well as the company's corporate progress and other developments.
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside Board Member and ASPN Co-Founder and Vice Chairman, Dr. Dawood Sayed ROSELAND, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced preliminary, unaudited revenue for the second quarter ending June 30, 2026.
Milestone Scientific Strengthens Board to Support Next Phase of Growth
ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a series of strategic governance initiatives designed to support the Company's continued evolution and long-term growth.
Similar companies
-
Precision Optics Corporation, Inc.
POCI
·
NASDAQ
Compare
-
IGC Pharma, Inc.
IGC
·
New York Stock Exchange Arca
Compare
-
NEXGEL, Inc.
NXGL
·
NASDAQ
Compare
-
Myomo, Inc.
MYO
·
New York Stock Exchange Arca
Compare
-
Retractable Technologies, Inc.
RVP
·
New York Stock Exchange Arca
Compare
-
MIRA Pharmaceuticals, Inc.
MIRA
·
NASDAQ
Compare